This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Albert Einstein College of Medicine, University of Pittsburgh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 514 
1 out of 1,963 
Years Active: 2025
Title: Mary Frances Cacace: Innovator in Sulfotransferase Inhibition
Introduction
Mary Frances Cacace is a notable inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of biochemistry, particularly in the area of sulfotransferase inhibition. Her work has implications for various therapeutic applications.
Latest Patents
Mary Frances Cacace holds a patent for "Small molecule inhibition of sulfotransferase SULT1A3." This patent describes small molecule compounds and methods for inhibiting human sulfotransferase 1A3 (SULT1A3). The patent also discloses methods of manufacturing and treatment using these compounds. She has 1 patent to her name.
Career Highlights
Throughout her career, Cacace has been associated with prestigious institutions such as the University of Pittsburgh and Albert Einstein College of Medicine. Her research has focused on developing innovative solutions to complex biochemical challenges.
Collaborations
Mary Frances Cacace has collaborated with esteemed colleagues, including Alexander Deiters and Ting Wang. These partnerships have enhanced her research and contributed to her success in the field.
Conclusion
Mary Frances Cacace is a pioneering inventor whose work in sulfotransferase inhibition has the potential to impact therapeutic strategies. Her contributions to science and collaboration with other researchers highlight her commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile